MHE State of the Industry survey: COVID-19 ranks No.1

MHE conducted our annual State of the Industry reader survey in October and November. Respondents were asked to rank the importance of healthcare issues and, no surprise, 71% of the rankings of COVID-19 by the respondents rated it as the number one healthcare issue. High drug prices were ranked as second most important healthcare issue by 29% of the respondents.

We also asked respondents to rank their level of agreement with a variety of statements about U.S. healthcare. Agreement was strongest (56%) with the statement, “The increasing enrollment in Medicare Advantage is a positive development,” and the strongest disagreement (62%) was with the statement, “Drug prices are high, but high prices mean investment in research and development.”